WallStSmart

RenX Enterprises Corp. (RENX)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 143042% more annual revenue ($11.77B vs $8.22M). WELL leads profitability with a 12.0% profit margin vs -194.1%. WELL earns a higher WallStSmart Score of 57/100 (C).

RENX

Hold

38

out of 100

Grade: F

Growth: 6.3Profit: 2.0Value: 5.0Quality: 3.0
Piotroski: 4/9Altman Z: -4.64

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for RENX.

WELLSignificantly Overvalued (-58.0%)

Margin of Safety

-58.0%

Fair Value

$131.57

Current Price

$212.09

$80.52 premium

UndervaluedFair: $131.57Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RENX2 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
4229.0%10/10

Revenue surging 4229.0% year-over-year

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
162.6%10/10

Earnings expanding 162.6% YoY

Market CapQuality
$153.42B9/10

Large-cap with strong market position

Areas to Watch

RENX4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.57M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-608.0%2/10

ROE of -608.0% — below average capital efficiency

Free Cash FlowQuality
$-10.29M2/10

Negative free cash flow — burning cash

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

PEG RatioValuation
3.662/10

Expensive relative to growth rate

P/E RatioValuation
105.5x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : RENX

The strongest argument for RENX centers on Price/Book, Revenue Growth. Revenue growth of 4229.0% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : RENX

The primary concerns for RENX are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 14.28 is elevated, increasing financial risk.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.5x leaves little room for execution misses.

Key Dynamics to Monitor

RENX profiles as a hypergrowth stock while WELL is a growth play — different risk/reward profiles.

RENX carries more volatility with a beta of 3.87 — expect wider price swings.

RENX is growing revenue faster at 4229.0% — sustainability is the question.

WELL generates stronger free cash flow (647M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 38/100) and 38.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

RenX Enterprises Corp.

REAL ESTATE · REAL ESTATE - DEVELOPMENT · USA

RELX NV, through its interest in RELX Group plc, provides information and analysis for professional and commercial clients in all industries globally. The company is headquartered in Amsterdam, the Netherlands.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?